- Home
- TOVX vs IDAI Comparison
TOVX vs IDAI Comparison
Compare TOVX & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- IDAI
- Stock Information
- Founded
- TOVX 2001
- IDAI 2016
- Country
- TOVX United States
- IDAI United States
- Employees
- TOVX N/A
- IDAI N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- TOVX Health Care
- IDAI Technology
- Exchange
- TOVX Nasdaq
- IDAI Nasdaq
- Market Cap
- TOVX 4.5M
- IDAI 4.9M
- IPO Year
- TOVX 2006
- IDAI N/A
- Fundamental
- Price
- TOVX $0.42
- IDAI $3.03
- Analyst Decision
- TOVX Hold
- IDAI
- Analyst Count
- TOVX 1
- IDAI 0
- Target Price
- TOVX N/A
- IDAI N/A
- AVG Volume (30 Days)
- TOVX 1.2M
- IDAI 24.9K
- Earning Date
- TOVX 08-11-2025
- IDAI 08-14-2025
- Dividend Yield
- TOVX N/A
- IDAI N/A
- EPS Growth
- TOVX N/A
- IDAI N/A
- EPS
- TOVX N/A
- IDAI N/A
- Revenue
- TOVX N/A
- IDAI $3,366,415.00
- Revenue This Year
- TOVX N/A
- IDAI $65.46
- Revenue Next Year
- TOVX N/A
- IDAI $12.00
- P/E Ratio
- TOVX N/A
- IDAI N/A
- Revenue Growth
- TOVX N/A
- IDAI N/A
- 52 Week Low
- TOVX $0.37
- IDAI $1.43
- 52 Week High
- TOVX $7.15
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- TOVX 44.90
- IDAI 56.73
- Support Level
- TOVX $0.45
- IDAI $2.62
- Resistance Level
- TOVX $0.47
- IDAI $2.90
- Average True Range (ATR)
- TOVX 0.04
- IDAI 0.20
- MACD
- TOVX 0.00
- IDAI -0.01
- Stochastic Oscillator
- TOVX 31.76
- IDAI 75.65
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.